וקסיגריפ

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE VIRUS; A/SINGAPORE/INFIMH-16-0019/2016 (H3N2) - LIKE VIRUS; B/COLORADO/06/2017- LIKE VIRUS (B/VICTORIA/2/87 LINEAGE); B/PHUKET/3073/2013 - LIKE VIRUS (B/YAMAGATA/16/88 LINEAGE)

Disponible depuis:

MEDICI MEDICAL LTD, ISRAEL

Code ATC:

J07BB01

forme pharmaceutique:

תרחיף להזרקה

Composition:

B/PHUKET/3073/2013 - LIKE VIRUS (B/YAMAGATA/16/88 LINEAGE) 15 MCG/DOSE; A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE VIRUS 15 MCG/DOSE; A/SINGAPORE/INFIMH-16-0019/2016 (H3N2) - LIKE VIRUS 15 MCG/DOSE; B/COLORADO/06/2017- LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) 15 MCG/DOSE

Mode d'administration:

תוך-שרירי, תת-עורי עמוק

Type d'ordonnance:

מרשם נדרש

Fabriqué par:

SANOFI PASTEUR, FRANCE

Groupe thérapeutique:

INFLUENZA, INACTIVATED, WHOLE VIRUS

Domaine thérapeutique:

INFLUENZA, INACTIVATED, WHOLE VIRUS

indications thérapeutiques:

For the prevention of influenza.

Date de l'autorisation:

2012-11-30